Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2005
05/19/2005WO2005006958A3 Modulation of ceacam1 expression
05/19/2005WO2005004585A3 Precise breeding
05/19/2005WO2005003350A8 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER’S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)
05/19/2005WO2004108755A3 Chimeric adenovirus capsid proteins
05/19/2005WO2004104190A3 Methods and compositions for the production of adenoviral vectors
05/19/2005WO2004098526A3 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
05/19/2005WO2004094590A3 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
05/19/2005WO2004093778A8 Oligonucleotides that block toll-like receptors
05/19/2005WO2004085615A3 Glucosidases, nucleic acids encoding them and methods for making and using them
05/19/2005WO2004083402A3 Spleen necrosis predictive genes
05/19/2005WO2004072264A3 Fate determination by hes 1 in hematopoietic stem-progenitor cells and uses thereof
05/19/2005WO2004060912A3 Chimeric capsid proteins and expression vectors for monocistronic expression of multiple genes
05/19/2005WO2004045495A3 Interacting site for gp41 on gp120 of hiv-1
05/19/2005WO2004044141A3 Conjugated oligomeric compounds and their use in gene modulation
05/19/2005WO2004041924A3 Non-phosphorous-linked oligomeric compounds and their use in gene modulation
05/19/2005WO2004031351A3 Microarrays having multiple oligonucleotides in single array features
05/19/2005WO2004029222A3 Pathogen-responsive genes, promoters, regulatory elements, and methods of use for same
05/19/2005WO2004024871A3 Antibodies and methods for generating genetically altered antibodies with high affinity
05/19/2005WO2004024749A3 Thermostable reverse transcriptases and uses thereof
05/19/2005WO2004024079A3 Methods and compositions for production of flavonoid and isoflavonoid nutraceuticals
05/19/2005WO2004022762A9 Orthopoxvirus vectors, genes and products thereof
05/19/2005WO2004016764A3 eNOS MUTANTS USEFUL FOR GENE THERAPY
05/19/2005WO2004016726A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
05/19/2005WO2004016224A3 Antisense modulation of vegf co-regulated chemokine-1 expression
05/19/2005WO2004015125A9 Process for preparing peptides with anti-hypertensive properties
05/19/2005WO2003092592A3 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
05/19/2005WO2003083042A3 Pathogen-induced promoters
05/19/2005WO2003066805A3 Antisense modulation of complement component c3 expression
05/19/2005WO2003061601A3 Aminophospholipid transporter atpase
05/19/2005WO2003057713A3 Proteases producing an altered immunogenic response and methods of making and using the same
05/19/2005WO2003029419A3 Three dimensional structure of crystalline grp94 binding domain, and its methods of use
05/19/2005WO2003014703A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
05/19/2005WO2003012035A3 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins
05/19/2005WO2001098480A8 Promoters for regulation of plant gene expression
05/19/2005US20050108793 Auxin-inducible gene, ARGOS, that is involved in organ development, including size control, in plants; transgenic plants
05/19/2005US20050108792 Plastid transformation vector comprising anthrax protective antigen for use in generation of edible vaccines for conferring immunity to mammal against bacillus anthracis
05/19/2005US20050108791 Transgenic plants with improved phenotypes
05/19/2005US20050108790 Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same
05/19/2005US20050108788 Genes participating in the synthesis of fatty acid having trans-11-,cis-13-conjugated double bond and utilization thereof
05/19/2005US20050108787 Plant expression vector comprising nucleotide sequences coding acetohydroxyacid synthase (AHAS) for use as tool in generating imidazolinone herbicide resistant plants
05/19/2005US20050108786 Promoter molecules for use in plants
05/19/2005US20050108785 Using nuclear transplantation as tool in generating transgenic cells for treatment and prevention of liver, nervous system, cardiovascular and bone disorders; regenerative medicine
05/19/2005US20050108784 Expression vector comprising nucleotide sequences coding spinocerebellar ataxia-1 gene for use in treatment and prevention of nervous system disorders
05/19/2005US20050108783 Porcine invariant chain protein, full length cDNA, genomic organization, and regulatory region
05/19/2005US20050108782 Transgenic RS1-/- animal and uses thereof
05/19/2005US20050108781 Expression vector comprising nucleotide sequences coding heterologous polypeptides for use as gene transfer and expression tool; bioreactors
05/19/2005US20050107961 Apparatus for managing gene expression data
05/19/2005US20050107960 Describing and storing method of alignment information
05/19/2005US20050107601 Nucleotide sequences coding immunoglobulin fusion specific to heparan sulfate proteoglycans for use as diagnostic and therapeutic tool in treatment and prevention of neurodegenerative and cell proliferative disorders
05/19/2005US20050107597 Nucleotide sequences coding microorganismal secondary response gene (SPA-1) for as tool in diagnosis, prevention and treatment of pseudomonal infection
05/19/2005US20050107592 Lipid binding protein 1
05/19/2005US20050107591 Cysteine variants of erythropoietin
05/19/2005US20050107590 Mutated constitutively active nuclear ophan receptor
05/19/2005US20050107589 Membrane fusion protein for use as toole in the treatment and prevention of inflammatory bowel and autoimmune diseases
05/19/2005US20050107587 Hdv nucleic acid molecules fragments and applications thereof
05/19/2005US20050107363 administering to mammals drugs such as 5,10-dihydro-4,6,8-trihydroxy-10-(3,7,11-trimethyl-trans-2,trans-6,10-dodecatrienyl)-11H-dibenzo[b,e][1,4]diazepin-11-one, as anticarcinogenic agents
05/19/2005US20050107332 Starch process
05/19/2005US20050107328 Antisense modulation of polo-like kinase expression
05/19/2005US20050107326 GENETIC ENGINEERED nucleic acid, VECTOR CODING ANTISENSE AGENTS; FOR USE IN KILLING PREFERENTIAL TARGET CELLS OR MICRORGANISMS; biodrugs as antitumor agent, bactericides, anticarcinogenic agent; target on antibiotic resistant bacteria, drug-resistant cancer cells
05/19/2005US20050107324 Nucleotide sequences for inhibiting the expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule, coronavirus receptor; prevent coronavirus infections, SARS (Severe Acute Respiratory Syndrome); viricide biodrugs
05/19/2005US20050107323 Cardiac arrhythmia treatment methods
05/19/2005US20050107318 Methods of treating diabetes and other blood sugar disorders
05/19/2005US20050107317 Nucleic acid molecule of the short-chain dehydrogenase gene family, an antibody, an aptamer or receptors, polypeptide encoded thereby; biodrug for treatment of metabolism of triglycerides, metabolic disorders as obesity, eating disorder, cachexia, diabetes mellitus, hypertension, heart disease
05/19/2005US20050107316 Enzyme inhibitor of polo like kinase, duplex RNAs antisense oligonucleotides, short interfering RNA as anticarcinogenic agent biodrug
05/19/2005US20050107314 Modulation of cd200 receptors
05/19/2005US20050107301 administering to a mammal an effective amount of an anti-thrombin protein from the salivary glands of the species, low toxicity, little or no antigenicity, short clearance time from circulation
05/19/2005US20050107299 Assays for novel serotonin transporter (SERT) blockers
05/19/2005US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
05/19/2005US20050107258 Auxinic analogues of indole-3-acetic acid
05/19/2005US20050106742 Using acoustic surface waves or electrowetting to transport liquids across substrate suface to preferential detection zones
05/19/2005US20050106734 Fungal micro-organism having an increased ability to carry out biotechnological process(es)
05/19/2005US20050106733 Double-stranded cyclic dna capable of proliferating as a bacterial e coli chromosome
05/19/2005US20050106732 Pseudotyped with nucleotide sequence encoding envelope protein; transducing or infecting adipose tissue cells; metabolic disorders
05/19/2005US20050106731 siRNA-mediated gene silencing with viral vectors
05/19/2005US20050106730 Compositions and methods utilizing stable reporter cell lines for detection of pathway-specific signal transduction
05/19/2005US20050106729 Gene transfer methods and compositions
05/19/2005US20050106726 RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)
05/19/2005US20050106724 Self renewing dental follicle tissues for use in generating periodontal ligament like membrane structures; tissue repair and regenerative medicine
05/19/2005US20050106722 Efficient production of IgA in recombinant mammalian cells
05/19/2005US20050106719 Method of efficiently recombining orf encoded by cdna and template vector, trap vector and primer to be used therein
05/19/2005US20050106700 Using immobilized cohesin domains as affinity tools in recovery of dockerin polypeptides
05/19/2005US20050106699 Process for xylanase production
05/19/2005US20050106695 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
05/19/2005US20050106693 Metabolically engineered bacterial strains having enhanced 2-keto-D-gluconate accumulation
05/19/2005US20050106688 Using escherichia comprising enhanced concentrations of guanosine-3'-diphosphate-5'-diphosphate as bioreactor for propagation of glutamic acid
05/19/2005US20050106687 Using transgenic gramnegative bacteria as bioreactor for fermentation of threonine for use in medicine, cosmetics and animal feeds
05/19/2005US20050106682 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
05/19/2005US20050106680 Interferon-like protein Zcyto21
05/19/2005US20050106679 Leptin proteins
05/19/2005US20050106678 Human circulating cytokine CC-1
05/19/2005US20050106677 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata
05/19/2005US20050106676 Novel proteins having hemolytic activity and genes encoding the protein
05/19/2005US20050106675 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/19/2005US20050106674 Ephrin receptor binding protein for use as tool in treatment and prevention of cell proliferative and nervous system disorders
05/19/2005US20050106672 Neurotransmission associated proteins
05/19/2005US20050106671 Expression vector, host cell and method for producing fusion proteins
05/19/2005US20050106670 Isolated human G-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human GPCR proteins, and uses thereof
05/19/2005US20050106669 Specific polynucleotides encoding them, as well as expression vectors and host cells; used for identifying compounds that inhibit an interaction between a Glutamate Transporter Associated Protein and a glutamate transporter protein, and for treating disorders associated with glutamate transport.
05/19/2005US20050106668 Proteases from gram-positive organisms
05/19/2005US20050106667 Variant complementary determining regions for use in identifying antigen binding polypeptides; mimetics; direceted protein evolution
1 ... 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 ... 4023